Get in Touch
Trivalent Therapeutics welcomes inquiries from pharmaceutical companies, investors, and research institutions interested in licensing our patent-protected methods for treating alcohol use disorder. Reach out using the details below and a member of our team will respond promptly.
When contacting us regarding our intellectual property, please reference U.S. Nonprovisional Utility Patent Application No. 19/705,839 — Methods of Treating Alcohol Use Disorder and Related Conditions Using Retatrutide.
Email our licensing team directly and we'll arrange a conversation about how our methods can support your development program.
Email Licensing Team